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The long term goal of the Nuclear Receptor Signaling Atlas (NURSA) resides in unraveling the physiological
and pathological functions of nuclear receptors (NRs) at the molecular, biochemical and cellular levels.This
multi-oriented task requires complementary approaches in order to determine the specific function(s) and
precise expression and receptor activity patterns for each individual conventional or orphan receptor.To
attain this objective, we have chose to turn to technologies recently made available to engineer bacterial
artificial chromosomes (BACs).
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Introduction
The long term goal of the Nuclear Receptor Signaling
Atlas (NURSA) resides in unraveling the physiological
and pathological functions of nuclear receptors (NRs) at
the molecular, biochemical and cellular levels.This
multi-oriented task requires complementary approaches
in order to determine the specific function(s) and precise
expression and receptor activity patterns for each
individual conventional or orphan receptor.
Figure 1. Modification of BAC plasmid by homologous
recombination: linear recombination. The linear recombination
construct is flanked by two homologous regions (A and B) for the targeted
BAC clone and contains a prokaryotic selection marker (Sm) for the
selection of recombinant-containing bacteria. Electrocompetent cells cells
containing the BAC (BAC or PAC) are prepared and induced to express
the recombination function (rec+).The recombinant construct is then
introduced in these cells by electroporation and the recombinants are
selected against the selection marker (Sm).
To attain this objective, we have chose to turn to
technologies recently made available to engineer bacterial
artificial chromosomes (BACs), E. coli F factor based
vectors capable of maintaining cloned DNA fragments
up to 300 kb. Due to their large size, BAC clones are
more likely to contain the informative sequences
necessary for directing the expression of transgenes in
an appropriate spatio-temporal expression pattern,
making them more amenable to study NRs.
BAC mediated transgenesis has indeed proven to be a
highly reliable way to obtain accurate transgene targeting
for in vivo studies of gene expression and function. BAC
engineering technologies have been developed on the
concept of homologous recombination in E. coli [Copeland
et al., 2001; Lee et al., 2001; Muyrers et al., 2001;Yu et
al., 2000; Zhang et al., 1998] and allow virtually any
modification to be performed at any chosen position,
including insertions, deletions, replacements and point
mutations. Hence, NR gene-containing BAC clones can
be isolated from a genomic BAC library and modified to
introduce the features desired for the study of any
particular aspect of the NR biology.
After presenting the BAC engineering system by
homologous recombination, we will describe different
transgene designs that we envision to address the
questions of NR function, expression pattern and activity.
Modification of BACs by homologous
recombination
Two main settings have been used to modify BACs by
homologous recombination in E. coli, the first one
involving RecA-mediated recombination with circular DNA
[Gong et al., 2002;Yang et al., 1999], while in the second,
linear DNA recombination is performed [Lee et al., 2001;
Muyrers et al., 2000; Muyrers et al., 1999;Yu et al., 2000].
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through freely-chosen homology regions, making possible
the alteration of the target molecule at any position. In
the first system, a circular plasmid DNA is designed to
express the recombination function in the form of the
RecA protein in addition to one or two regions
homologous to the target, allowing the introduction of
diverse modifications in the BAC (Figure 1).
For the second recombination system, RecBCD
exonuclease activity is removed to allow for the use of
linear DNA by expressing the gam gene or by using
RecBCD deficient bacterial strains.The recombination is
then performed by double strand break repair enzymes
from bacterial (RecE/RecT, [Muyrers et al., 2000; Muyrers
et al., 1999]) or prophage (Red-α/Red-β, [Lee et al., 2001;
Muyrers et al., 2000]) origins (Figure 2).
Figure 2. Modification of a BAC plasmid by homologous
recombination in the bacteria: circular recombination. The targeting
plasmid consists of a selectable and counter-selectable marker (Sm–Csm),
a temperature-sensitive origin of replication (ts-ori), the recA gene and
two homology regions (A and B). In the first round of homologous
recombination, recombination can take place through either homology
arm (A or B; for simplicity, only recombination through A is shown here),
which results in the formation of a co-integrant.The co-integrant is
identified by selection for the selectable gene at a temperature that is not
permissive for the ts-ori. In the second round of homologous
recombination, resolution of the cointegrant is driven by applying
counter-selection against the counter-selectable gene at a temperature
that is permissive for the ts-ori. Resolution can either revert the
co-integrant to the original target molecule or generate the recombinant.
Overall, the modification of NR gene-containing BAC
clones allows the rapid generation of transgenic
constructs to study the different aspects of NR biology.
For defining the precise expression pattern of NRs,
reporter transgenes such as fluorescent proteins or
enzymatic reporters, such as the β –galactosidase,
luciferase or the alkaline phosphatase genes, can be
inserted into the NR gene locus. Each specific reporter
presents different advantages and weaknesses in regard
to their respective sensitivity, and spatial and temporal
resolution (reporter gene design, Figure 3A).
Figure 3. BAC plasmid modification – reporter gene design and
activity trap setting. A.Transgenes generated from the recombination
of the NR-containing BAC with this type of targeting construct will place
the expression of the reporter gene under the control of the promoter and
regulatory regions present in the BAC and are likely to recapitulate the
expression pattern of the NR considered. Note: it is also possible to
generate knock-out constructs with this approach, providing that a
eukaryotic promoter (Pr.) is introduced in the construct in order to allow
selection of recombinant ES cells with an appropriate selection marker
(Sm* – dual selection marker, for prokaryotic and eukaryotic selection).
Homologous recombination allows for more complex designs than the
one presented here. B. Activity trap setting.This particular design results
in the replacement of the endogenous DNA-binding domain (DBD) by the
Gal4 DBD. Activation of a reporter gene upon binding of the chimeric
protein to Gal4 UAS sequences (inset) should parallel the activity of the
endogenous NR.
Figure 4. BAC plasmid modification – ligand trap setting. A version
slightly different from Figure 3B.The expression of this fusion gene will
activate reporter gene expression upon binding of LBD by (putative)
ligand(s). A, B: regions of homology designed for recombination; Sm:
Selection marker; Pr.: Eukaryotic promoter; DBD: DNA-Binding Domain;
LBD: Ligand Binding Domain ; NR: Nuclear Receptor; frt: recombination
sites for the Flt recombinase (for removal of the selection marker in a
subsequent step).
For receptor activity studies, the DNA-binding domain
(DBD) of the NR considered can be replaced by another
DBD not active in mammalian cells, such as the well
characterized Gal4 DBD, in such a way that the chimeric
NR will then activate the expression of a reporter
transgene (activity trap setting, Figure 3B). In a slightly
different approach, ligand-activated receptor activity can
also be addressed more specifically if the LBD of the NR
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is coupled to the Gal4 DBD to activate a reporter gene
(ligand trap setting, Figure 4).
Finally, homologous recombination in E. Coli has been
shown to be an efficient tool to generate gene-targeting
vector constructions, whether complex or not, for the
targeted disruption of genes in embryonic stem (ES) cells
(Figure 2A).This method provides a simple way to
produce sophisticated genomic manipulations such as
conditional knock-outs. In addition, it has been
demonstrated recently that intact BAC clones can be used
to specifically target genes in ES cells with high targeting
efficiencies.
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